Last updated: March 3, 2026
What is the excipient composition of Rexall Anti-Diarrheal?
Rexall Anti-Diarrheal tablets typically contain the active ingredient loperamide hydrochloride at a dosage of 2 mg per tablet, supplemented with excipients that optimize stability, bioavailability, and shelf life. Common excipients include microcrystalline cellulose as a filler, croscarmellose sodium for disintegration, magnesium stearate as a lubricant, and pharmaceutical-grade coloring agents.
Table 1: Typical excipient components in Rexall Anti-Diarrheal
| Excipients |
Function |
Specifics |
| Microcrystalline cellulose |
Filler, binder |
Provides bulk, ensures uniformity |
| Croscarmellose sodium |
Disintegrant |
Promotes rapid tablet disintegration |
| Magnesium stearate |
Lubricant |
Prevents sticking during manufacturing |
| Coloring agents |
Branding, identification |
FD&C dyes, such as titanium dioxide |
Note: Precise formulation details are proprietary but follow standard pharmaceutical guidelines.
How does excipient choice influence the drug's stability and bioavailability?
Excipients directly impact the physical stability and dissolution profile of Rexall Anti-Diarrheal. Microcrystalline cellulose ensures the tablet remains intact during storage, resisting moisture and temperature fluctuations. Croscarmellose sodium facilitates quick disintegration, essential for rapid relief. Magnesium stearate minimizes friction during compression, which can influence uniformity and, indirectly, bioavailability.
What are the commercial implications of excipient strategies?
Strategic selection of excipients influences manufacturing efficiency, cost, shelf life, and patient compliance. Using widely available, cost-effective excipients such as microcrystalline cellulose and magnesium stearate reduces production costs and ensures consistent supply. Additionally, selecting excipients compatible with over-the-counter (OTC) regulations simplifies compliance and market entry.
What opportunities exist for excipient innovation in Rexall Anti-Diarrheal?
Advances in functionality and patient experience provide avenues for differentiation:
- Biodegradable or plant-based excipients: Responds to demand for natural and sustainable formulations.
- Taste-masking agents: Improve palatability for pediatric or sensitive patients.
- Enhanced disintegrants: Quicker dissolution can improve onset of action.
- Stabilizers for moisture-sensitive APIs: Extend shelf life, particularly in tropical markets.
Investment in excipient formulation R&D can secure competitive advantages, especially with innovations that align with consumer preferences or regulatory trends.
What are the regulatory considerations for excipient substitution or innovation?
Excipients must meet pharmacopeial standards (USP, EP, or JP) and comply with specific OTC drug regulations. Any novel excipients require safety and tolerability data, often entailing additional regulatory review. A change in excipient composition affects stability data and manufacturing procedures, necessitating supplementary filings (e.g., supplemental NDA or ANDA).
How does global demand affect excipient sourcing and formulation?
The OTC diarrhea segment demonstrates steady growth, particularly in emerging markets, driven by increased access to healthcare. This demands scalable, cost-effective excipient sourcing strategies. Manufacturers seek reliable suppliers compliant with local and international standards.
What are the key takeaways?
- Excipients in Rexall Anti-Diarrheal influence stability, onset, shelf life, and patient compliance.
- Cost-effective, regulatory-compliant excipient choices streamline manufacturing and market entry.
- Innovation opportunities include natural excipients, taste-masking, and enhanced disintegration properties.
- Regulatory pathways for excipient change involve rigorous testing and approval processes.
- Global demand emphasizes the importance of scalable sourcing and formulation flexibility.
FAQs
1. Can excipient modifications improve the absorption rate of Rexall Anti-Diarrheal?
Yes. Incorporating excipients such as disintegrants with faster action or bioavailability enhancers can speed up drug release.
2. Are natural excipients viable for OTC anti-diarrheal formulations?
Yes. Plant-based excipients like pullulan or hydroxypropyl methylcellulose are gaining acceptance and can appeal to health-conscious consumers.
3. How does excipient choice influence shelf life?
Excipients must stabilize the API and prevent moisture ingress. Using moisture barriers and stabilizers extends shelf life.
4. What regulatory hurdles exist for novel excipients?
Novel excipients require extensive safety data, potential GRAS (Generally Recognized As Safe) status, and regulatory approval, increasing time and cost.
5. What are the key regulatory standards for OTC anti-diarrheal excipients?
Standards include USP, EP, or JP pharmacopeial monographs, as well as compliance with OTC labeling and safety regulations per FDA and EMA guidelines.
References
- U.S. Pharmacopeia. (2023). USP-NF Monographs.
- European Pharmacopoeia. (2023). General Notices and Monographs.
- Food and Drug Administration. (2022). Guidance for Industry: Nonprescription Drug Labeling.
- International Conference on Harmonisation. (2020). Q3: Impurities in New Drug Substances and Products.
- MarketWatch. (2023). Over-the-counter diarrhea medication market report.
Note: Specific proprietary formulation details for Rexall Anti-Diarrheal are commercially confidential and are based on general industry standards.
